Actinium-225 Prostate-specific Membrane Antigen Theranostics: Will alpha Beat beta?
- Author(s)
- Dhiantravan, N; Hofman, MS; Ravi Kumar, AS;
- Details
- Publication Year 2021-03,Volume 79,Issue #3,Page 351-352
- Journal Title
- European Urology
- Publication Type
- Commentary
- Abstract
- Optimisation of prostate-specific membrane antigen (PSMA) based radioligand therapy (RLT) requires a focus on prospective trials.
- Keywords
- Actinium; Humans; Male; *Precision Medicine; Prospective Studies; *Prostate
- Department(s)
- Cancer Imaging
- PubMed ID
- 33436167
- Publisher's Version
- https://doi.org/10.1016/j.eururo.2020.12.011
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-01-30 05:59:56
Last Modified: 2026-01-30 06:01:39